Financhill
Back

Matinas BioPharma Holdings Vs. Merck & Industry Stock Comparison

Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.63
Seasonality Move:
10.6%
Sell
25

MRK
Merck &

Last Price:
99.13
Seasonality Move:
3.55%
Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.62. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Merck & (MRK) is a Sell

Is Merck & a Buy, Sell or Hold?

  • The current Merck & [MRK] share price is $99.18. The Score for MRK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.

MRK Stock Price Chart

What is Merck &'s stock price today?

  • The Merck & share price today is $99.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRK is experiencing selling pressure, which indicates risk of future bearish movement.

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 25.5 Sell
Chaikin Money Flow: 22780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.21 - 2.65) Sell
Bollinger Bands (100): ( - 3.16) Sell

MRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.64 Sell
Relative Strength Index (14 RSI): 39.25 Sell
Chaikin Money Flow: -11216635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.27 - 104.65) Sell
Bollinger Bands (100): (104.64 - 121.72) Sell

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Buy
20-day SMA: 0.93 Sell
50-day SMA: 2.45 Sell
200-day SMA: 0.89 Sell
8-day EMA: 0.64 Sell
20-day EMA: 1.09 Sell
50-day EMA: 1.69 Sell
200-day EMA: 1.18 Sell

MRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.84 Buy
20-day SMA: 100.37 Sell
50-day SMA: 107.22 Sell
200-day SMA: 120.42 Sell
8-day EMA: 98.61 Buy
20-day EMA: 100.63 Sell
50-day EMA: 105.79 Sell
200-day EMA: 114.66 Sell

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.

Merck & Earnings Growth & MRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.36 per share, and an increase next year of $1.75 per share.

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merck & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):